Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC Label Exemption Procedure Clarification Urged By CTFA

This article was originally published in The Tan Sheet

Executive Summary

FDA should establish a well-defined process for manufacturers to file for exemptions under the OTC labeling final rule, the Cosmetic, Toiletry & Fragrance Association maintains in comments filed with FDA's Division of OTC Drugs Dec. 13.

You may also be interested in...



Block Drug Labeling Exemption Request For BC Analgesic Powder Denied

Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder was denied by FDA Aug. 28.

Block Drug Labeling Exemption Request For BC Analgesic Powder Denied

Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder was denied by FDA Aug. 28.

Block Drug Labeling Exemption Request For BC Analgesic Powder Denied

Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder was denied by FDA Aug. 28.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090701

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel